FDA Finds Quality Breaches At J&J Drug Plant

Law360, New York (December 17, 2010, 4:20 PM EST) -- U.S. Food and Drug Administration inspectors have uncovered flaws in quality control at a Johnson & Johnson plant that produced recalled children's medicine and was shut down in April after the FDA discovered bacterial contamination, dust and grime at the site.

The agency released its inspection report Wednesday following a six-week inspection of J&J's Fort Washington, Pa., plant, operated by J&J division McNeil Consumer Healthcare. The plant was the source of children's medicine, including Children's and Infant's Tylenol, Motrin, Zyrtec and Benadryl, recalled in May after...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.